|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||31.38 - 31.60|
|52-week range||31.38 - 31.60|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||16 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
JERSEY CITY, N.J., March 07, 2023--Organon Launches "Her Plan is Her Power," a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
JERSEY CITY, N.J., February 16, 2023--Organon (NYSE: OGN) today announced its results for the fourth quarter and full year ended December 31, 2022.
JERSEY CITY, N.J., February 06, 2023--Organon (NYSE: OGN), a global women’s healthcare company will release its fourth quarter and full year 2022 financial results on February 16, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.